Central Serous Chorioretinopathy: Clinical Characteristics Associated with Visual Outcomes
Authors:
- 18 August 2018
- journal article
- research article
- Published by Taylor & Francis in Seminars in Ophthalmology
- Vol. 33 (6) , 804-807
Abstract
Purpose: Retrospective cohort study to identify clinical characteristics associated with poor visual acuity in central serous chorioretinopathy (CSC). Materials and Methods: Charts of patients in a tertiary referral clinic diagnosed with CSC over a 13-year period were reviewed. Multivariate logistic regression analyses were performed to assess the relationship between several clinical characteristics and final visual acuity. Results: Of 353 subjects with CSC, 258 had a minimum of 2 clinical assessments and adequate follow-up. Multivariate analysis showed that the followings were significantly associated with worse final visual acuity: older age at diagnosis, history of photodynamic therapy, choroidal neovascularization (CNV), hypertension, and either prostate cancer or benign prostatic hypertrophy. Diabetes mellitus was associated with better final visual acuity. In a subgroup analysis of 150 subjects with at least 1 year of follow-up, CNV, hypertension, and gastroesophageal reflux disease were significantly associated with worsening of visual acuity over the study period. Use of a psychiatric medication at presentation was protective. Conclusion: Poor visual outcomes in CSC are associated with older age at diagnosis, CNV, hypertension, and history of prostate disease. Several clinical characteristics that have been identified as risk factors for developing CSC also appear to be associated with worse visual outcomes.Keywords
Funding Information
- Research to Prevent Blindness
This publication has 16 references indexed in Scilit:
- Systemic Factors Associated with Central Serous Chorioretinopathy in KoreansKorean Journal of Ophthalmology, 2012
- The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002Ophthalmology, 2008
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2004
- Risk factors for central serous chorioretinopathyOphthalmology, 2004
- Systemic findings associated with central serous chorioretinopathyAmerican Journal of Ophthalmology, 1999
- INDOCYANINE GREEN VIDEOANGIOGRAPHY OF OLDER PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHYRetina, 1996
- Type A behaviour and prevalent heart disease in the Caerphilly study: increase in risk or symptom reporting?Journal of Epidemiology and Community Health, 1988
- Long-term follow-up of central serous chorioretinopathy.British Journal of Ophthalmology, 1984
- Experimental Central Serous Chorioretinopathy in Monkey Eyes: Fluorescein Angiographic FindingsOphthalmologica, 1982
- Experience With Nontreatment of Central Serous ChoroidopathyArchives of Ophthalmology (1950), 1974